Experienced in Upper Tract Urothelial Carcinoma (UTUC)

Bobby Shayegan

Hamilton, ON, CA 
Experienced in Upper Tract Urothelial Carcinoma (UTUC)
Hamilton, ON, CA 
OverviewLocationsClinical Research

Overview

Bobby Shayegan practices in Hamilton, Canada. Shayegan is rated as an Experienced expert by MediFind in the treatment of Upper Tract Urothelial Carcinoma (UTUC). Their top areas of expertise are Prostate Cancer, Bladder Cancer, Muscle Invasive Bladder Cancer, Prostatectomy, and Cystectomy.

Their clinical research consists of co-authoring 165 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Locations

Hamilton, ON, Canada
Other Locations
Hamilton, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

PSMA PET/CT Guided Intensification of Therapy in Patients at Risk of Advanced Prostate Cancer
PSMA PET/CT Guided Intensification of Therapy in Patients at Risk of Advanced Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: March 13, 2025
Intervention Type: Other, Diagnostic test
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled Trial of Metformin in Reducing Progression Among Men on Expectant Management for Low Risk Prostate Cancer: The MAST (Metformin Active Surveillance Trial) Study
A Randomized, Double-Blind, Placebo-Controlled Trial of Metformin in Reducing Progression Among Men on Expectant Management for Low Risk Prostate Cancer: The MAST (Metformin Active Surveillance Trial) Study
Enrollment Status: Active_not_recruiting
Publish Date: January 24, 2024
Intervention Type: Drug
Study Drug: Metformin
Study Phase: Phase 3
A Phase I/IIa Study Evaluating the Safety and Tolerability of Intratumoral Administration of ORCA-010 in Treatment-Naïve Patients With Localized Prostate Cancer.
A Phase I/IIa Study Evaluating the Safety and Tolerability of Intratumoral Administration of ORCA-010 in Treatment-Naïve Patients With Localized Prostate Cancer.
Enrollment Status: Active_not_recruiting
Publish Date: October 31, 2023
Intervention Type: Biological
Study Drug: ORCA-010
Study Phase: Phase 1/Phase 2
Tranexamic Acid During Cystectomy Trial (TACT)
Tranexamic Acid During Cystectomy Trial (TACT)
Enrollment Status: Completed
Publish Date: October 04, 2022
Intervention Type: Drug
Study Drug: Tranexamic Acid
Study Phase: Phase 2/Phase 3
View 3 Less Clinical Trials

165 Total Publications

Comparison of 90-day morbidity and mortality between ileal conduit and orthotopic neobladder following radical cystectomy in a large multi-institutional database: The Canadian CBCIS experience.
Comparison of 90-day morbidity and mortality between ileal conduit and orthotopic neobladder following radical cystectomy in a large multi-institutional database: The Canadian CBCIS experience.
Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada
Published: October 08, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Shayegan's expertise for a condition
ConditionClose
    View All 13 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile